SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
MEDEL ROGER MD

(Last) (First) (Middle)
1301 CONCORD TERRACE

(Street)
SUNRISE FL 33323-2825

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PEDIATRIX MEDICAL GROUP INC [ PDX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
CHIEF EXECUTIVE OFFICER
3. Date of Earliest Transaction (Month/Day/Year)
11/02/2005
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/02/2005 M 19,000 A $25.3 52,333 D
Common Stock 11/02/2005 S(1) 19,000 D $80.0685 33,333 D
Common Stock 11/03/2005 11/04/2005(2) M 11,133 A $25.3 44,466 D
Common Stock 11/03/2005 11/04/2005(2) M 25,000 A $36.3 69,466 D
Common Stock 11/03/2005 11/04/2005(2) M 14,867 A $38.125 84,333 D
Common Stock 11/03/2005 11/04/2005(2) S(1) 51,000 D $80.6916 33,333 D
Common Stock 11/04/2005 M 12,300 A $38.125 45,633 D
Common Stock 11/04/2005 S(1) 12,300 D $0 33,333 D
Common Stock 240 I BY CHILD
Common Stock 11/03/2005 11/04/2005(2) M 10,000 A $32.875 10,000 I BY SPOUSE
Common Stock 11/03/2005 11/04/2005(2) S(1) 10,000 D $80.6916 0 I BY SPOUSE
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to buy) $25.3 11/02/2005 M 19,000(3) 04/02/2004 04/02/2013 Common Stock 19,000 $0 77,800 D
Stock Options (Right to buy) $25.3 11/03/2005 11/04/2005(2) M 11,133(3) 04/02/2004 04/02/2013 Common Stock 11,133 $0 66,667 D
Stock Options (Right to buy) $36.3 11/03/2005 11/04/2005(2) M 25,000(4) 12/15/2001 12/15/2011 Common Stock 25,000 $0 0 D
Stock Option $38.125 11/03/2005 11/04/2005(2) M 14,867(5) 01/28/1999 01/28/2008 Common Stock 14,867 $0 35,133 D
Stock Option $38.125 11/04/2005 M 12,300(5) 01/28/1999 01/28/2008 Common Stock 12,300 $0 22,833 D
Stock Option $32.875 11/03/2005 11/04/2005(2) M 10,000(6) 11/20/1997 11/20/2006 Common Stock 10,000 $0 0 I BY SPOUSE
Explanation of Responses:
1. This sale has been executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective February 9, 2004.
2. This transaction was executed pursuant to a Rule 10b5-1 trading plan. Broker notified reporting person of the transaction November 4, 2005, the deemed execution date.
3. Options granted pursuant to the Company's Amended and Restated Stock Option Plan. Options became exercisable on April 2, 2004.
4. Options granted pursuant to the Company's Amended and Restated Stock Option Plan. Options became exercisable on December 15, 2001.
5. Options granted pursuant to the Company's Amended and Restated Stock Option Plan. Options became exercisable on January 28, 1999.
6. Options granted to Dr. Medel's spouse, pursuant to the Company's Amended and Restated Stock Option Plan. Options became exercisable on November 20, 1997.
By: Thomas W. Hawkins 11/04/2005
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.